Loading...
The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective
BACKGROUND: Fast-acting insulin aspart is a new formulation of the rapid-acting insulin analogue insulin aspart and represents an advancement over current rapid-acting insulin analogues in terms of onset of action and postprandial glucose control. The objective of the current analysis was to demonst...
Na minha lista:
| Udgivet i: | Ther Adv Endocrinol Metab |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6022975/ https://ncbi.nlm.nih.gov/pubmed/29977497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018818766816 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|